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Background and objective. Beta-blocker overdose may result in intractable cardiovascular collapse despite conventional antidotal
treatments. High dose insulin/glucose (ING), and more recently intravenous lipid emulsion (ILE), have been proposed as
potentially beneﬁcial therapies in beta blocker intoxication. We compare eﬃcacy of the novel antidotes ING, with ILE, in a rabbit
model of combined enteric/intravenous propranolol toxicity. Methods. Sedated, mechanically ventilated and invasively monitored
New Zealand White rabbits underwent mini-laparotomy and enterostomy formation with 40mg/kg propranolol instilled into the
proximal small bowel. At 30 minutes propranolol infusion was commenced at 4mg/kg/hr and continued to a target mean arterial
pressure (MAP) of 50% baseline MAP. Animals were resuscitated with insulin at 3U/kg plus 0.5g/kg glucose (ING group), or
10mL/kg 20% Intralipid (ILE group). Results.R a t ep r e s s u r ep r o d u c t( R P P ;R P P=heart rate × mean arterial pressure) was greatest
intheINGgroupat60minutes(P<. 05).AtrendtowardgreaterheartratewasobservedintheINGgroup(P = .06).Nodiﬀerence
was observed in survival between groups (4/5 ING versus 2/5 ILE; P = .524). Conclusions. High dose insulin resulted in greater
rate pressure product compared with lipid emulsion in this rabbit model of severe enteric/intravenous propranolol toxicity.
1.Introduction
Beta-adrenergic-blocking drugs are invaluable in treating
a range of cardiovascular and noncardiovascular medical
conditions. Accidental and intentional overdose may, how-
ever, result in intractable cardiovascular collapse. Reversal
of bradycardia, negative inotropism, and restoration of
critical organ perfusion are immediate goals of treatment.
Propranolol is a lipophilic, nonselective, beta-blocker with
additional sodium channel blocking activity [1]. These
unique features are thought to contribute to the increased
mortality associated with propranolol intoxication when
compared with poisoning from other beta-blocking agents
[2].
Numerous therapies have been advocated as useful in
severe beta-blocker poisoning including volume expansion,
atropine, calcium, cardiac pacing, infusion of inotropic and
vasoactive medications, gastrointestinal decontamination,
and charcoal hemodiaﬁltration [3]. Glucagon is furthermore
known to exert a positive inotropic and chronotropic
eﬀect on the myocardium by stimulating adenyl cyclase
through a separate receptor to that of catecholamines [4, 5].
Although widely employed, however, glucagon has failed
when administered as sole antidotal therapy in a number of
clinical reports of beta-blocker intoxication [6–8].
More recently a number of novel therapies have been
forwarded as potentially useful in beta-blocker overdose.
Levosimendan, a calcium sensitizer, has been demonstrated
to improve survival when compared with both placebo and
dopamine in a swine model of severe propranolol toxicity
[9]. High-dose insulin/dextrose euglycaemia has addition-
ally been demonstrated superior to both glucagon and
adrenaline, and combination vasopressin and adrenaline,
in canine [10] and porcine [11] models of propranolol2 Critical Care Research and Practice
intoxication, respectively. Insulin use has been employed
in greater than 68 reported cases of calcium channel
blocker/beta-blocker overdose with largely positive cardio-
dynamic, and hemodynamic responses [3], albeit few of
these reported ING applications in single agent beta-blocker
poisoning.
Our study group has additionally demonstrated im-
provements in hemodynamic performance with infusion
of lipid emulsions in propranolol-induced hypotension in
whole rabbits [12]. No beneﬁt was demonstrated in similar
models of toxicity from the more hydrophilic beta-blockers
atenolol [13], and metoprolol [14]. Sequestration of highly
lipophilic toxins to an expanded intravascular lipid phase
and augmentation of free fatty acid metabolism have been
forwarded as potential beneﬁcial mechanisms of action of
intravenous lipid emulsions [15–17]. Demonstrated eﬃcacy
for ILE in cardioactive agents of elevated lipophilicity
appears consistent with the former thesis.
Apaucityofcomparativedataexiststoguidetheclinician
faced with a patient in profound cardiovascular collapse sec-
ondary to propranolol poisoning, when choosing to institute
one or more of these novel therapies. Accordingly this study
was undertaken to evaluate the eﬀects of insulin and glucose
(ING) and intravenous lipid emulsion (ILE) in an animal
model of propranolol toxicity. Speciﬁcally we determined to
compare hemodynamic performance following ING versus
ILE therapy in an intact rabbit model of propranolol-
induced shock.
2. Methods
This study was performed at the Ruakura Animal Research
Centre, Hamilton, New Zealand. All study protocols were
reviewed and approved by the Ruakura Animal Ethics Com-
mittee. Animal utilization was in accord with institutional
guidelines for ethical animal experimentation.
2.1.ExperimentalModel. FourteenadultNewZealandWhite
Rabbits (age 95–114 days) of mixed gender were studied.
Prior to study animals were housed in single-sex enclosures
with no chance of pregnancy. Unfettered access to feed and
water was permitted until the day utilization.
On the day of study rabbits were sedated with ketamine
(MaynePharmaLtd,NewZealand)at50mg/kg,andxylazine
(Bayer HealthCare, Germany) at 4mg/kg via intramuscular
injection. Animals were then placed on a surgical board and
underwent venous cannulation of the marginal vein of the
ear. Intravenous Ketamine bolus (10mg) was administered
prior to subsequent invasive procedures. Three lead ECGs
were sited, with continuous monitoring of standard limb
lead two.
Formal tracheostomy was preformed with 3.0mm inter-
nal diameter endotracheal tube secured by taping, and
mechanical ventilation initiated with 100% oxygen titrated
to 10cm H2O inspiratory pressure at 27 breaths per
minute (Nuﬃeld series 200 paediatric ventilator, Penlon
Ltd, Abington, England). Inspiratory:expiratory ratio was
set at 0.2:2.0. End tidal CO2 was assessed with continuous
colour-change capnography (C-CO2,V i t a lS i g n sC o l o r a d o
Ltd, USA) with CO2 maintained in the 2–5% range prior
to induction of toxicity. Vecuronium (Pharmaco Ltd, New
Zealand) at 0.1mg/kg was administered following establish-
ment of mechanical ventilation, and repeated at 20 minute
intervals to maintain paralysis.
Blunt dissection was employed to expose the common
carotid artery on the right before cannulation with a 20
G saline ﬁlled vascular catheter advanced to the proximal
aorta.Thiswasconnectedinstandardfashion(EdwardsLife-
sciences pressure transducer, Irvine, CA, USA) to Hewlett-
Packard 78834A neonatal monitor for continuous assess-
mentofinvasivearterialbloodpressure.Minilaparotomywas
preformed with identiﬁcation of the junction of the ﬁrst and
second parts of the duodenum. Enterostomy (5mm) was
created and a catheter tipped feeding tube passed distally
for a distance of 25cm into the small bowel. A ten-minute
period of stabilization was aﬀorded following completion
of invasive procedures at which time baseline hemodynamic
metrics were obtained.
2.2. Induction Toxicity. Propranolol (Cardinol,P a c i ﬁ cP h a r -
maceuticals, Auckland, New Zealand) tablets at 40mg/kg
were crushed and added to 20mL/kg sterile water. This
was instilled via the enteric feeding tube during gradual
withdrawal, ensuring uniform delivery of slurry over the
instrumented small bowel. The tube was then removed, and
enterostomy and laparotomy closed.
At 30 minutes propranolol 0.3mg/kg (Inderal,W y e t h
Pharmaceuticals Inc, Phil, USA) was injected intravenously
and thereafter continued at 4mg/kg/hour until mean arterial
pressure (MAP) equaled 50% baseline MAP. At this point
propranolol infusion was discontinued.
2.3. Resuscitation Protocol. Animals were entered into intra-
venous lipid emulsion (ILE) or insulin and glucose (ING)
treatment arms (n = 5 all groups) according to prior
randomization. At the deﬁned point of toxicity animals
in the ILE group received 10mL/kg 20% Lipid emulsion
(Intralipid, Fresenius Kabi AB, Sweden) injected over a
ﬁve minute interval. Animals in the IN/G group received
3u/kg insulin (Actrapid, Novo Nordisk AS, Denmark),
0.5g/kg glucose, and 7mL/kg 0.9% saline solution over
ﬁve minutes. All rabbits were monitored for 60 minutes
following administration of study agents with acquisition of
hemodynamic metrics at one minute intervals.
In the event of cardiovascular collapse (deﬁned by
mean arterial pressure of less than or equal to 20mmHg)
ILE-treated animals received a further 3mL/kg 20%
Intralipid infused over one minute. Adrenaline (Hospira,
New Zealand) 100mcg/kg was administered and repeated
at 5 minute intervals, and external chest compressions
(approximating 30% anterior-posterior chest wall diameter
at 180 beats per minute) commenced. Mechanical ven-
tilation continued unabated. External chest compressions
were discontinued for ﬁve seconds every minute to assess
native hemodynamic parameters. Return of spontaneous
circulation (ROSC) was deﬁned by an MAP of greaterCritical Care Research and Practice 3
than or equal to 50mmHg with restoration of perfusing
native heart rhythm, for 120 seconds or longer. Animals
failing to exhibit ROSC at ten minutes following onset of
cardiovascular collapse underwent crossover treatment to
receive 3u/kg insulin, 0.5g/kg glucose, and 2mL/kg 0.9%
saline solution over one minute. Basic life support (BLS)
resuscitative measures and bolus adrenaline administration
were continued until termination of the monitoring interval.
Animals from the ING group exhibiting cardiovascular
collapse received a further 3u/kg insulin, 0.5g/kg glucose,
and 2mL/kg 0.9% saline solution over one minute. BLS
resuscitation and bolus adrenaline were likewise continued
for ten minutes. Animals failing to exhibit ROSC then
underwent crossover to receive 3mL/kg 20% Intralipid
infusedoveroneminute.InsimilarfashionBLSresuscitation
and repeated bolus adrenaline was continued to termination
of the monitoring interval.
At the termination of study protocols all surviv-
ing animals were killed with intravenous pentobarbitone
(300mg/kg) overdose. Necropsy was performed to conﬁrm
appropriate positioning of endotracheal tube and vascular
catheters, and absence of peritoneal hemorrhage.
2.4. Data Acquisition. Heart rate and invasive blood pressure
(systolic, diastolic, mean arterial pressure (MAP)) were
recorded directly from the monitoring system to standard-
ized data collection template at one-minute intervals. Heart
rate (HR) was recorded to the nearest beat per minute
and blood pressure to the nearest mmHg. Rate pressure
product (RPP; RPP = HR × MAP) was adopted as the key
measure of cardiovascular performance given incorporation
of the depressant eﬀect of propranolol on both cardiac
chronotropic and inotropic states.
2.5.StatisticalAnalysis. Statisticalanalysisofallvariableswas
performed using GraphPad Prism 5 (GraphPad Software,
SanDiego,CA).Followingassessmentfornormalitywiththe
Kolmogorov-Smirnov test animal characteristics and base-
line hemodynamic parameters were compared via Student’s
t-testing. All hemodynamic metrics were compared across
time by two-way repeated measures analysis of variance
(ANOVA)withBonferroniposttestingwhensigniﬁcancewas
achieved (α<0.05). Survival rates were compared as a
secondary variable of interest using Fisher’s exact statistics.
All metrics are presented as mean (SEM) unless otherwise
stated. A two-tailed P<. 05 was retained as statistically
signiﬁcant.
3. Results
Animal characteristics and baseline hemodynamic parame-
ters are presented in Table 1. All metrics passed the Kolmog-
orov-Smirnov test for normality. There were no diﬀerences
in any parameter between groups.
Total propranolol dosing to toxicity was 41.9
(0.73)mg/kg in the ING group, and 41.9 (0.64)mg/kg
in the ILE group. Intravenous propranolol was 1.92 (0.73)
in the insulin group and 1.90 (0.64) in the ILE group. Rate
Table 1: Animal characteristics and baseline parameters according
to group.
ING (n = 5) ILE (n = 5)
Age (days) 110 (4) 104 (5)
Gender(M:F) 4:1 3:2
Weight (g) 3200 (32) 3094 (94)
Baseline heart rate (min−1) 204 (5) 198 (5)
Baseline MAP (mmHg) 79 (3) 76 (4)
Baseline RPP (mmHg·min−1) 16090 (373) 15100 (820)
Continuous data presented as mean (SEM).
























Figure 1: Rate pressure product (RPP) versus time.
pressure product served as the key measure of cardiac
performance in this model and is displayed graphically in
Figure 1. A trend toward greater RPP was observed in the
insulin-treated group (P = .076; RMANOVA). A signiﬁcant
diﬀerential in RPP was observed at 60 minutes.
Mean arterial pressure and heart rate across time are
presented graphically in Figures 2 and 3,r e s p e c t i v e l y .N o
statistically signiﬁcant diﬀerence was observed in MAP
between groups (P = .106; RMANOVA). A trend toward
greater heart rate in the insulin-treated group was observed
(P = .06; RMANOVA). At toxicity all animals exhibited
visible widening of ECG QRS duration consistent with
the known sodium channel blocking eﬀect of propranolol.
Limitations in monitoring equipment however precluded
capture and subsequent further interrogation of key ECG
metrics.
At termination of the study protocol one animal (1/5)
from the insulin-treated group and three animals (3/5)
from the ILE group were undergoing resuscitative treatment
following manifest cardiovascular collapse (P = .524).
No animal from either group exhibited ROSC following
cardiovascular collapse with initial resuscitative therapy, or

















Figure 2: Mean arterial pressure (MAP) versus time.
Necropsy revealed appropriate endotracheal tube, and
vascular catheter positioning in all animals. No evidence of
signiﬁcant hemoperitoneum was observed in any animal.
4. Discussion
In this pilot model of severe propranolol intoxication,
high-dose insulin (ING) therapy resulted in superior rate
pressure product at 60 minutes when compared with
intravenous lipid emulsion (ILE). Insulin administration
was likewise associated with a trend toward greater ame-
lioration of propranolol-induced bradycardia. No diﬀerence
was observed in survival between groups, albeit the study
was powered to detect all-or-none diﬀerences in categorical
variables only. No animal from either grouping exhibited
return of spontaneous circulation following cardiovascular
collapse with ING or ILE resuscitative treatments adminis-
tered individually or in combination.
In keeping with the goals of the present experiment
(to evaluate ING and ILE in isolation) we did not employ
either a placebo arm, or a standard treatment (atropine,
calcium, glucagon, and volume expansion) arm, in the study
protocol of this experiment. Similarly due to the preliminary
nature of the study hypothesis and unique model utilized,
no combination ING/ILE treatment arm was included as
initial resuscitation. While these limitations mitigate against
recommendation for clinical application, it would appear
that ING is superior therapy to ILE in this model of severe
propranolol poisoning.
Although incompletely elucidated, the beneﬁcial eﬀect
of insulin in drug-induced shock may be due to its role
in carbohydrate metabolism [10]. Under normal conditions
myocytes prefer free fatty acids as substrate for generation
ofhigh-energyphosphatecompounds.Duringdrug-induced
shock this preferred substrate is known to shift from free
fatty acids to carbohydrates [17, 18]. Cardiac uptake and


















Figure 3: Heart rate versus time.
blocker intoxication due to hypoinsulinaemia and acquired
insulin resistance [19–21], eﬀects reversed in the presence
of insulin. Importantly improvements in cardiac function
following insulin administration occur in the absence of
increased myocardial work [18, 22]. In contrast treatment
withcalcium,glucagon,andcatecholamine’sallpromotefree
fatty acid utilization, and subsequently increased myocardial
work [18]. In addition to improving myocardial glucose
utilization, insulin is furthermore known to increase levels
of plasma calcium, improve the hyperglycaemic acidotic
state associated with drug-induced shock, and exert an
independent inotropic eﬀect [23, 24]. This inotropic eﬀect
is heightened in stressed myocardium, and in beta-blocker
cardiotoxicity in particular [25].
Clinical experience with insulin is favorable. High-dose
insulin euglycaemia has been utilized in greater than 68
reports of calcium channel blocker and/or beta-blocker
overdose with most authors reporting favorable cardiovas-
cular performance with insulin administration [10]. While
less frequent, the instances of insulin use in sole beta-
blocker overdose similarly reﬂect improvement in reported
hemodynamic metrics.
Intravenouslipidemulsionshavegarneredrecentinterest
as antidotal therapy in nonlocal-anaesthetic lipophilic drug
toxidromes [26–28] following a decade of experimental
and clinical use in high lipophilicity local anaesthetic
cardiotoxicity [29, 30]. Two main hypotheses have been
forwarded to explain the beneﬁcial eﬀects observed with
ILE application [30]. In the ﬁrst, lipid infusion serves to
create an expanded plasma lipid phase (sink), into which
highly lipophilic toxins are sequestered away from their
pharmacologic sites of action. Expedited redistribution to
less vital lipid rich tissues may additionally be associated
with enhanced toxin carriage [31]. The second mechanism
proposesaugmentedmyocardiallipidmetabolismwithbolus
free fatty acid administration overcoming pharmacologic
impediments to fatty acid oxidation known to be associated
with responsive toxic agents [30].Critical Care Research and Practice 5
Limited experimental evidence with ILE in animal mod-
els of beta-blocker intoxication has suggested beneﬁt with
lipid application in agents of elevated lipophilicity. Bania
and coworkers have demonstrated increased mean arterial
pressure (MAP) in propranolol toxic rodents following ILE
infusion [32]. Similarly our study group has demonstrated
greater hemodynamic performance in rabbits resuscitated
from propranolol-induced hypotension with ILE compared
placebo [12], but nil beneﬁt in similar models of the more
hydrophilic beta-blockers atenolol [13] and metoprolol [14]
thereby providing inferential support to the “lipid sink”
hypothesis.
Clinical reports of ILE use in beta-blocker toxicity are
emerging. In one case report ILE application resulted in
dramatic improvements in hemodynamic performance with
reversal of overt shock repeatedly in a patient suﬀering
massiveverapamilandatenololoverdose.Theimprovements
were however nonsustained and the patient eventually
died despite maximal conventional therapies, repeated ILE
bolus, and intra-aortic balloon counterpulsation [33]. In
a further report of atenolol self-poisoning a 46-year-old
female received 100mL of ILE over one hour resulting in
stabilization of blood pressure following the development of
symptomatic hypotension [34]. The patient survived.
Two literature reports describe combined ING/ILE use
in beta-blocker intoxication. A 48-year-old man was suc-
cessfully resuscitated from nebivolol-induced bradyasystolic
cardiac arrest with 100mL 20% ILE following failure of con-
ventional antidotal therapies. Subsequent transient hyper-
tension was attributed to unopposed epinephrine eﬀect on
beta adrenergic receptors previously occupied by nebivolol,
yetrenderedunoccupiedthroughproposedmyocardialtoxin
washout in accord with lipid sink thesis. The patient
subsequently received high-dose insulin cotherapy and sur-
vived [35]. In the second, a 31-year-old woman remained
hypotensive following massive carvedilol ingestion despite
volume expansion, high dose dopamine infusion, calcium
chloride bolus’s, glucagon, epinephrine infusion, and an
intensive insulin regimen. Following ILE bolus and infusion
blood pressure normalized and she was rapidly weaned from
vasopressors and insulin [36]. Signiﬁcantly carvedilol shares
with propranolol the commonality of high lipid solubility
(Log P carvedilol 3.29 [37]; propranolol 2.80 [38]).
In the context of the available experimental and clinical
data, and on the basis of postulated beneﬁcial mechanisms
of action of the two agents, it would appear that high-
dose insulin has demonstrated more consistent eﬃcacy
and clinical utility than ILE in beta-blocker intoxication.
ILE has nevertheless been shown to aﬀect recovery in
clinical scenarios of cardiotoxicity attributable to beta-
blocking agents of elevated lipophilicity, when conventional
therapies—including high-dose insulin, have proven ineﬀec-
tual. While clinical recommendation based on incomplete
data is fraught, high-dose insulin therapy may be consid-
ered preferential to ILE in the majority of beta-blocker
poisonings, with consideration given to ILE for intoxications
characterized by greater lipophilicity of the oﬀending agent.
Some features of the animal model employed in the
present work warrant further mention. The decision to
instrument the small bowel and deliver propranolol enteri-
cally represents a signiﬁcant deviation from previous models
which have employed continuous intravenous infusions
of toxin as mimic for ongoing gastrointestinal absorption
[11]. Enterostomy was nevertheless elected following initial
dose ranging experiments with orogastric tube insertion
(4 animals) that failed to result in overt pharmacologic
eﬀect within suﬃcient time frame to feasibly study. Given
little is known about mesenteric blood ﬂows and intesti-
nal absorption of propranolol during intoxication-induced
shock states, this was considered more likely to reﬂect the
ongoing gastrointestinal absorption expected following oral
overdose. Intravenous infusion was however retained to
achieve a toxic hemodynamic endpoint in a timely fashion.
In this study we elected intramuscular ketamine/xylazine
combination as sedation in line with both institutional pro-
tocol, and previous demonstrated cardiovascular stability of
these agents in similar models of toxicity [12–14]. Ketamine
is nevertheless known to exhibit intrinsic sympathomimetic
activity which may have partially mitigated the beta adrener-
gic blocking eﬀects of propranolol. We are therefore unable
to exclude a confounding eﬀect of ketamine on observed
outcomes. All animals however received a pharmacologically
available preparation of propranolol, and behaved in a
fashion consistent with beta-blocker intoxication.
This study is subject to a number of additional limita-
tions. The study was by nature a preliminary pilot study
aimed at establishing a model for future trials. The small
number of animals in each group rendering the trial insuf-
ﬁciently powered to detect anything but larger diﬀerences
in categorical variables (ROSC, survival). These data may
however be gainfully employed to power future work with
these metrics as primary outcome variables. The experiment
was additionally performed by investigators unblinded to
key study interventions. Acquisition of study metrics were
however obtained directly from monitoring equipment to
standardizeddatacollectiontemplateinasystematicfashion.
The study furthermore failed to obtain blood gas analysis
at baseline, toxicity, or 60 minutes. As such we are unable
to compare important physiologic parameters prior to,
and following, propranolol infusion. All animals however
received identical care, and received mechanical ventilation
with identical settings. Similarly we have been unable to
collate serum glucose and potassium concentrations dur-
ing the course of the experimental protocol. Signiﬁcant
hypoglycaemia is however unlikely given the glucose bolus
administered concurrently with insulin. Finally we adopted
3IU/kg as initial bolus in the ING group. This represents
threetimesthedosagegenerallyemployed(recommendation
1IU/kg [3]) yet aﬀorded greatest potential for observing a
positive eﬀect on outcomes.
5. Conclusion
In this rabbit model of severe enteric/intravenous propra-
nolol toxicity high-dose insulin resulted in greater hemody-
namic recovery compared with intravenous lipid emulsion.
Further experimental work is indicated to guide clinical6 Critical Care Research and Practice
recommendations for lipid emulsion therapy in beta-blocker
poisoning.
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